Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice

  • 18 Accesses

  • 3 Citations

Summary

Reserpine given after nialamide or parygline is 15–20 times more toxic in aggregated than in isolated mice.

Hyperthermia and hypermotility produced by reserpine after MAO inhibitor pretreatment are considerably greater in aggregated than in isolated mice.

The increasee toxicity is related to the change of brain monamine level, because it is diminished by α-methyl-m-tyrosine and prenylamine; quantitative relationship could not be established.

This is a preview of subscription content, log in to check access.

References

  1. Amin, A. H., T. B. Crawford, and J. H. Gaddum: The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J. Physiol. (Lond.) 126, 596–618 (1954).

  2. Askew, B. M.: Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice. Brit. J. Pharmacol. 19, 245–257 (1962).

  3. Burn, J. H., and R. Hobbs: A test for tranquillizing drugs. Arch. int. Pharmacodyn. 113, 290–295 (1958).

  4. Chance, M. R. A.: Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J. Pharmacol. exp. Ther. 87, 214–219 (1946).

  5. Fleming, R. M., W. G. Clark, E. D. Fenster, and J. C. Towne: Single extraction method for the simultaneous fluorometric determination of serotonin, dopamine, and norepinephrine in brain. Analyt. Chem. 37, 692–696 (1965).

  6. Moore, K. E.: Toxicity and catecholamine releasing actions of d- and l-amphetamine in isolated and aggregated mice. J. Pharmacol. exp. Ther. 142, 6–12 (1963).

  7. L. C. Sawdy, and S. R. Shaul: Effects of d-aphetamine on blood glucose and tissue glycogen levels of isolated and aggregated mice. Biochem. Pharmacol. 14, 197–204 (1965).

  8. Paasonen, M. K., and O. Krayer: The release of norepinephrine from the mammalian heart by reserpine. J. Pharmacol. exp. Ther. 123, 153–160 (1958).

  9. Pfeifer, A. K., E. Sz. Vizi, É. Sátory, and É. Galambos: Effect of reserpine on the metabolic centers. Arch. int. Pharmacodyn. 149, 126–135 (1964).

  10. Shore, P. A., and B. B. Brodie: LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid. Proc. Soc. exp. Biol. (N. Y.) 94, 433–435 (1957).

  11. Vane, J. R.: A sensitive method for the assay of 5-hydroxy-tryptamine. Brit. J. Pharmacol. 12, 344–349 (1957).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pfeifer, A.K., Galambos, É. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice. Psychopharmacologia 11, 130–135 (1967). https://doi.org/10.1007/BF00401249

Download citation

Keywords

  • Toxicity
  • Monoamine
  • Monoamine Oxidase
  • Reserpine
  • Oxidase Inhibitor